Best Serotonin and Norepinephrine Reuptake Inhibitor for depressive disorder
2 Serotonin and Norepinephrine Reuptake Inhibitor drugs indicated for depressive disorder, ranked by our independent rating. The current highest-rated is venlafaxine hydrochloride. Compare them with all treatments for depressive disorder or the full Serotonin and Norepinephrine Reuptake Inhibitor class. Not medical advice — always consult a professional.
Top serotonin and norepinephrine reuptake inhibitor for depressive disorder: 1. Venlafaxine Hydrochloride · 2. Effexor XR
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Venlafaxine Hydrochloride | Not yet rated | Prescription | $4 | View → |
| 2 | Effexor XR | Not yet rated | Prescription | $4 | View → |
Full ranking · 2 drugs
venlafaxine hydrochloride
PrescriptionFDA-sourced
Venlafaxine hydrochloride extended-release capsule, USP is an extended-release capsule for once-a-day oral administration that contains venlafaxine hydrochloride USP a serotonin and norepinephrine reuptake inhibitor (SNRI).
serotonin and norepinephrine reuptake inhibitorattention deficit disorder with hyperactivityautistic disorder
Typical price
From ~$2.07/30· 8 forms Save up to 9% in classFrequently asked
- What is the best serotonin and norepinephrine reuptake inhibitor for depressive disorder?
- By our independent rating, venlafaxine hydrochloride currently ranks highest among Serotonin and Norepinephrine Reuptake Inhibitor drugs used for depressive disorder. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which serotonin and norepinephrine reuptake inhibitor drugs treat depressive disorder?
- pharmaranks lists 2 Serotonin and Norepinephrine Reuptake Inhibitor products indicated for depressive disorder, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
